Argenx SE (BE.ARGX) - 378.8 EUR (%)

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 377.4000 EUR
Ask 377.7000 EUR
Minim 373.0000 EUR
Maxim 379.1000 EUR
Pret referinta 373.9000
Volum -
Volum ultima zi 1
Max 52 sapt 494.0000 EUR
Min 52 sapt 273.4000 EUR

Descriere companie

Argenx SE, formerly arGEN X BV (https://www.argenx.com/), is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others.

Informatii companie

Nume

Argenx SE

Buna ziua, sunt TreVi. Spuneti-mi, va rog, cu ce informatii va pot fi de folos.